107 related articles for article (PubMed ID: 21740118)
1. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss.
Jahangiri A; Lamborn KR; Blevins L; Kunwar S; Aghi MK
J Neurosurg; 2012 Feb; 116(2):283-9. PubMed ID: 21740118
[TBL] [Abstract][Full Text] [Related]
2. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
[TBL] [Abstract][Full Text] [Related]
3. Cranial nerve dysfunction following Gamma Knife surgery for pituitary adenomas: long-term incidence and risk factors.
Cifarelli CP; Schlesinger DJ; Sheehan JP
J Neurosurg; 2012 Jun; 116(6):1304-10. PubMed ID: 22424563
[TBL] [Abstract][Full Text] [Related]
4. Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
Reddy R; Cudlip S; Byrne JV; Karavitaki N; Wass JA
Eur J Endocrinol; 2011 Nov; 165(5):739-44. PubMed ID: 21900406
[TBL] [Abstract][Full Text] [Related]
5. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
Cohen-Inbar O; Xu Z; Lee CC; Wu CC; Chytka T; Silva D; Sharma M; Radwan H; Grills IS; Nguyen B; Siddiqui Z; Mathieu D; Iorio-Morin C; Wolf A; Cifarelli CP; Cifarelli DT; Lunsford LD; Kondziolka D; Sheehan JP
J Neurooncol; 2017 Oct; 135(1):67-74. PubMed ID: 28913674
[TBL] [Abstract][Full Text] [Related]
7. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
Fernandez A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic factors associated with pituitary apoplexy.
Jahangiri A; Clark AJ; Han SJ; Kunwar S; Blevins LS; Aghi MK
J Neurosurg; 2013 Dec; 119(6):1432-6. PubMed ID: 23889139
[TBL] [Abstract][Full Text] [Related]
10. A machine learning approach to predict early outcomes after pituitary adenoma surgery.
Hollon TC; Parikh A; Pandian B; Tarpeh J; Orringer DA; Barkan AL; McKean EL; Sullivan SE
Neurosurg Focus; 2018 Nov; 45(5):E8. PubMed ID: 30453460
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
Starke RM; Williams BJ; Jane JA; Sheehan JP
J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
[TBL] [Abstract][Full Text] [Related]
13. Visual Outcome of Patients with Pituitary Adenomas Following Surgery and Its Contributory Factors at a Tertiary Hospital in Ghana.
Tagoe NN; Essuman VA; Bankah P; Dakurah T; Hewlett VK; Akpalu J; Ndanu TA
Ethiop J Health Sci; 2019 Jan; 29(1):895-902. PubMed ID: 30700957
[TBL] [Abstract][Full Text] [Related]
14. Unusual cause of visual symptoms after bilateral laser in situ keratomileusis.
Sandhu SS; Gnanaraj L; James A; Figueiredo FC
J Cataract Refract Surg; 2005 Feb; 31(2):446-9. PubMed ID: 15767173
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Pituitary Adenomas in Elderly and Younger Adults: Clinical Characteristics, Surgical Outcomes, and Prognosis.
Liu J; Li C; Xiao Q; Gan C; Chen X; Sun W; Li X; Xu Y; Chen J; Shu K; Lei T
J Am Geriatr Soc; 2015 Sep; 63(9):1924-30. PubMed ID: 26313332
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
[TBL] [Abstract][Full Text] [Related]
17. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
18. Vision-related quality of life after transsphenoidal surgery for pituitary adenoma.
Okamoto Y; Okamoto F; Yamada S; Honda M; Hiraoka T; Oshika T
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3405-10. PubMed ID: 20181847
[TBL] [Abstract][Full Text] [Related]
19. What is the natural history of nonoperated nonfunctioning pituitary adenomas?
Karavitaki N; Collison K; Halliday J; Byrne JV; Price P; Cudlip S; Wass JA
Clin Endocrinol (Oxf); 2007 Dec; 67(6):938-43. PubMed ID: 17692109
[TBL] [Abstract][Full Text] [Related]
20. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Buchfelder M
J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
